Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1991-12-19
1994-10-04
Hill, Jr., Robert J.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
4351721, 4352401, 4353201, 530350, 514 12, C12N 1512, A61K 3702
Patent
active
053525876
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to natriuretic peptides A(atrial), B(brain), and type C; and a novel natiuretic peptide receptor B (NPRB) having binding affinity for these peptides. The invention further relates to the synthesis and use of mammalian natriuretic peptide receptor B produced by recombinant means.
2. Description of the Background Art
Cardiovascular homeostasis is controlled by several distinct but interrelated regulatory pathways that modulate blood pressure, fluid volume and electrolyte composition. One component of this control system is a atrial natriuretic peptide (ANP), a 28 amino acid endocrine hormone that is released by ventricular cardiocytes in response to elevated arterial blood pressure and increased intravascular fluid volume..sup.2
Alpha atrial natriuretic peptide (aANP) or (ANP) and brain natriuretic peptide (BNP) and type C natriuretic peptide (CNP) are homologous polypeptide hormones involved in the regulation of fluid and electrolyte homeostasis (reviewed in 1, 2, and 31). These three natriuretic peptides apparently share common receptors and stimulate the intracellular production of cGMP as a second messenger.sup.1. Molecular cloning has defined two types of natriuretic peptide receptors. A 60-70 kd ANP-C receptor (NPRC) is not coupled to cGMP production and may function in the clearance of ANP.sup.3,4. A 120-140 kd NPRA receptor is a membrane form of guanylyl cyclase (GC) in which ligand binding to the extracellular domain activates the cytoplasmic GC domain.sup.5,6. Previous biochemical evidence (reviewed in ref. 24) had not suggested the presence of natriuretic peptide receptor-GC subtypes. The identification of an additional receptor which would bind to the two natriuretic peptide ligands, would indicate a hitherto unappreciated complexity to this system. If such a subtype existed, it would then be possible to determine the role of each of the possible receptor-GC/ligand combinations in cardiovascular regulation. Knowledge of the DNA encoding an additional ANP receptor would allow the recombinant production of novel receptor protein and could be used in diagnostic hybridization procedures for the detection of novel mammalian receptor encoding genes. The novel receptor could be used to detect additional unique natriuretic peptides or other ligands which bind.
It is an object of the present invention to provide in commercially useful quantities, novel mammalian NPRB from a therapeutically acceptable source, most preferably human NPRB. It is an additional object to prepare amino acid sequence and other variants of mammalian NPRB. Yet another object is to produce a DNA sequence encoding mammalian NPRB which will hybridize with naturally occurring DNA sequences encoding a mammalian NPRB. Still another object is to produce antibody specific for NPRB.
These and other objects of the invention will be apparent from the specification as a whole.
SUMMARY OF THE INVENTION
The objects of this invention have been accomplished by methods comprising the identification and cloning of the gene which codes for mammalian NPRB; determining the amino acid sequence of NPRB; incorporating the NPRB gene into an expression vector; transforming a suitable host with the vector; expressing the mammalian NPRB gene in such a host and recovering the mammalian NPRB from the cells or cell culture medium. The present invention makes it possible to produce NPRB and/or derivatives or variants thereof by recombinant techniques, as well as providing products and methods related to such NPRB; such as antibodies, allosteric regulatory molecules, competitive and non-competitive inhibitors, and pharmaceutical formulations.
The present invention is directed to the compositions and method of producing mammalian NPRB via recombinant DNA technology, including: 1) isolating, purifying, and identifying the structural identity and the existence of the mammalian NPRB receptor; 2) the discovery and identity of the entire cDNA sequence of the NPRB gene; 3) the construction of
REFERENCES:
patent: 5118615 (1992-06-01), Matsuo et al.
Fuller et al., 1988, J. Biol. Chem., 263, 9395.
Koesling et al., 1988, FEBS Letter, 239, 29.
Singh et al., 1988, Nature, 334, 708.
Song et al., 1988, FEBS Letter, 232, 125.
Masu et al., 1987 Nature, 329, 836.
Leitman, D. C. and Murad, F. Endocrinol. Metab. Clin. N. Am., 16:79-105 (1987).
Koller et al., "Selective Activation of the B Natriuretic Peptide Receptor by C-Type Natriuretic Peptide (CNP)", Science, 252: 120-123 (1991).
Kojima et al. "Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide", Biochem. Biophys. Res. Comm., 159(3): 1420-1426 (1989).
Bennett et al., "Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors", J. Biol. Chem., 266(34):23060-23067 (1991).
Schulz et al., Cell, vol. 58, 1155-1162, 1989.
Smith et al., Science, 238, 1704-1707, 1987.
Chinkers et al., Nature, 338:78-83 (1989).
Chang et al., Nature, 341:68-72 (1989).
Lowe et al., EMBO Journal, 8(5):1377-1384 (1989).
Baxter et al., Biotechnology, 6:529-546 (1988).
Oehlenschlager et al., Eur. Jour. of Pharmacology, 161:159-164 (1989).
Hirata et al., FEB 238(2):415-418 (1988).
Stewart et al., Neuroscience & Biobehavioral Reviews, 12:151-168 (1988).
Sudoh et al., Biochem and Biophy Res Comm. 168(2):863-870 (1990).
Chang Ming-Shi
Goeddel David V.
Lowe David G.
Fitts Renee A.
Genentech Inc.
Hill Jr. Robert J.
Lee Wendy M.
Teng Sally P.
LandOfFree
Compositions and methods for the synthesis of natriuretic protei does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the synthesis of natriuretic protei, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the synthesis of natriuretic protei will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-580780